Enabling tomorrow's therapies manufacturing for today's patients, with sound
KOLIBRI has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
KOLIBRI's investors include Bpifrance, Entrepreneurs First, SOSV, Creative Ventures, SOSV SF & NY (Fka IndieBio).
KOLIBRI is headquartered in Paris, France.
Enabling tomorrow's therapies manufacturing for today's patients, with sound
KOLIBRI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KOLIBRI — Funding & Investors." VCBacked, March 6, 2023, https://www.vcbacked.co/company/kolibri. Accessed November 13, 2026.
VCBacked. (2023). KOLIBRI — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/kolibri
{{cite web |title=KOLIBRI — Funding & Investors |url=https://www.vcbacked.co/company/kolibri |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at KOLIBRI? Request a listing update